(Q44492573)

3 December 2017

title

Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure (English)

1 reference

3 December 2017

0 references

0 references

Akemi Yoshida

1 reference

3 December 2017

Hatsue Ishibashi-Ueda

1 reference

3 December 2017

Naoaki Yamada

1 reference

3 December 2017

Hideaki Kanzaki

1 reference

3 December 2017

Takuya Hasegawa

1 reference

3 December 2017

Hiroyuki Takahama

1 reference

3 December 2017

Makoto Amaki

1 reference

3 December 2017

Masanori Asakura

1 reference

3 December 2017

Masafumi Kitakaze

1 reference

3 December 2017

publication date

1 February 2013

1 reference

European Journal of Heart Failure

3 December 2017

published in

1 reference

3 December 2017

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

166-175

1 reference

Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

An approach to endomyocardial biopsy interpretation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

The role of cardiovascular magnetic resonance imaging in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Detection of myocardial damage in patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Myocarditis: current trends in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

The pathology of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Socie

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Myocarditis as a precipitating factor for heart failure: evaluation and 1‐year follow‐up using cardiovascular magnetic resonance and endomyocardial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS206

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFS206

1 reference

3 December 2017

1 reference